Today: 11 March 2026

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

New Era Energy & Digital (NUAI) Stock Skyrockets on AI Data Center Dreams – Key Updates & Outlook

New Era Energy & Digital (NUAI) Stock Skyrockets on AI Data Center Dreams – Key Updates & Outlook

New Era Energy & Digital (NASDAQ: NUAI) shares jumped nearly 90% on Oct. 9, 2025, after announcing progress on its 1GW AI data center project in West Texas. The company, rebranded from New Era Helium in August, faces a Nasdaq delisting hearing on Oct. 16 despite recent financial moves and a brief market cap surge above $75 million.
USA Rare Earth Stock Skyrockets on Rare Earth Boom and White House Buzz – What’s Driving USAR’s Record High?

USA Rare Earth (USAR) Stock Soars on Rare Earth Boom and White House Buzz – What Investors Need to Know

USA Rare Earth (NASDAQ: USAR) shares surged over 120% year-to-date, closing in the low-$30s on Oct. 9, 2025, after news of White House talks and a $100 million acquisition of UK-based Less Common Metals. The company, still pre-revenue, is developing a Texas rare earth mine and Oklahoma magnet plant. USAR reported a Q2 net loss of $142 million, with about $120 million cash mid-2025.
Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Akero shares jumped nearly 19% to $55 on October 9, 2025 after Novo Nordisk announced a $5.2 billion buyout at $54 per share plus a $6 contingent payment. Novo will pay $4.7 billion upfront and another $500 million if Akero’s lead drug, efruxifermin, wins FDA approval by 2031. The deal has board approval and is expected to close by late 2025, pending regulatory and shareholder clearance.
Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Turn Therapeutics shares surged to around $23 midday Oct. 9 after opening at $24.50, following a prior close of $7. Market cap jumped to over $500 million from under $100 million. The stock debuted on Nasdaq Oct. 8 via direct listing and has traded with extreme volatility, more than tripling in value amid speculative interest. No new FDA approvals were announced this week.
Novo Nordisk’s $5.2 Billion Bet to Reverse Fatty Liver Disease – Game-Changer or Big Gamble?

Novo Nordisk’s $5.2 Billion Bet to Reverse Fatty Liver Disease – Game-Changer or Big Gamble?

Novo Nordisk will acquire Akero Therapeutics for up to $5.2 billion, paying $54 per share in cash plus a potential $6 per share if Akero’s lead drug wins U.S. approval by 2031. Akero’s efruxifermin, in Phase 3 trials for fatty liver disease, has shown reversal of liver fibrosis in mid-stage studies. Akero shares jumped 19% on the news, while Novo shares were little changed. The deal is expected to close by year-end.
PepsiCo (PEP) Stock: Q3 Earnings Surprise, “Ozempic Effect” Fears & Activist Investor Shake-Up – What’s Next?

PepsiCo (PEP) Stock: Q3 Earnings Surprise, “Ozempic Effect” Fears & Activist Investor Shake-Up – What’s Next?

PepsiCo shares trade near $139, down 6% in a month and 22% below last year’s high. Q3 revenue rose 2.6% to $23.94 billion, topping estimates, but North American snack and beverage volumes fell. Elliott Management disclosed a $4 billion stake, urging changes. Steve Schmitt was named CFO on Oct. 9, replacing retiring Hugh Johnston.
Double Meteor Shower Spectacle: Draconid and Orionid Displays Will Light Up October’s Night Sky

Meteor Storm or Moonlit Fizzle? Draconid ‘Dragon’ Meteor Shower Peaks Tonight with Skywatchers on Alert

The Draconid meteor shower peaks on the evening of October 8, 2025, just two days after a full Harvest Supermoon. Bright moonlight is expected to limit visibility to 2–6 meteors per hour. Scientists have predicted a possible outburst, but any surge may go largely unseen due to faint meteors and daylight timing in North America and Europe. The best viewing window is early evening on October 8, facing north.
Inside Deutsche Börse & Frankfurt Stock Exchange: Europe’s Financial Powerhouse Unveiled (2025 Update)

Inside Deutsche Börse & Frankfurt Stock Exchange: Europe’s Financial Powerhouse Unveiled (2025 Update)

Deutsche Börse AG operates the Frankfurt Stock Exchange, handling about 90% of German equity trading and hosting key indices like the DAX. Its stock trades near €230, valuing the group at €45–46 billion, with 2024 revenues at €5.83 billion. Recent moves include Ottobock’s IPO and partnerships with Circle and Chainlink. Analysts rate the stock Hold, with targets between €240 and €320.
9 October 2025
Gerresheimer Stock in Freefall After Another Profit Warning – Is the Worst Over?

Gerresheimer Stock in Freefall After Another Profit Warning – Is the Worst Over?

Gerresheimer cut its 2025 outlook after weak Q3 results, now expecting organic revenue to fall 2–4% and EBITDA margin to drop to 18.5–19%. Shares plunged 12% on Oct 9, hitting €33 and marking a year-to-date loss of over 50%. The company cited weak demand in cosmetics and oral liquid packaging. A BaFin probe into 2024 accounts and repeated guidance cuts have added pressure.
MedTech Giant’s IPO Shakes Up Market: Ottobock’s Blockbuster Debut Revives IPO Hopes

MedTech Giant’s IPO Shakes Up Market: Ottobock’s Blockbuster Debut Revives IPO Hopes

Ottobock shares opened at €72 on Oct. 9, 2025, jumping 9% above the €66 IPO price and briefly reached €73 amid strong demand. The IPO raised €808 million, valuing the prosthetics maker at €4.2 billion, marking Germany’s largest listing in over a year. The Näder family retains over 80% ownership, with about 19% of shares in free float. Ottobock reported €1.43 billion revenue last year and employs around 9,300 people.
9 October 2025
BMW’s Profit Warning Shocks Markets – Tariffs and China Slowdown Spark Stock Slide

BMW’s Profit Warning Shocks Markets – Tariffs and China Slowdown Spark Stock Slide

BMW cut its 2025 profit forecast, citing weaker China sales and delayed U.S.-EU tariff relief. The company now expects a slight decline in pre-tax earnings and halved its auto division cash flow outlook to over €2.5 billion. Shares dropped as much as 9%, erasing up to €7 billion in market value. Mercedes-Benz stock also fell after similar China and tariff pressures.
9 October 2025
Nvidia’s $4 Trillion AI Stock Surge: Record Highs, Mega Deals & Bold Forecasts

Nvidia’s $4 Trillion AI Stock Surge: Record Highs, Mega Deals & Bold Forecasts

Nvidia’s stock surged to a record $190 in early October 2025, briefly pushing its market cap past $4 trillion and overtaking Apple. Quarterly revenue jumped 56% to $46.7 billion, driven by AI chip demand. Nvidia announced a $100 billion partnership with OpenAI and a $5 billion stake in Intel. AMD’s new deal to supply OpenAI with AI chips sent its shares up 30%, but Nvidia retains over 90% of the AI accelerator market.
UiPath’s Automation Stock Soars on AI Buzz – Latest PATH Analysis & Outlook

UiPath’s Automation Stock Soars on AI Buzz – Latest PATH Analysis & Outlook

UiPath shares surged 5% to $15.58 on Oct. 8, nearing 2025 highs after a weeklong 20% rally and heavy trading volume. The move followed new AI partnerships with OpenAI, Google, NVIDIA, and Snowflake, and Q2 results that beat expectations with revenue up 14.6% to $362 million and a swing to a GAAP profit. Technical indicators show strong momentum but suggest overbought conditions. Wall Street consensus remains Hold.
9 October 2025
Euronext Paris Shocks Markets with Historic Roots, Surging Stocks & Bold 2025 Moves

Euronext Paris Shocks Markets with Historic Roots, Surging Stocks & Bold 2025 Moves

Euronext Paris, Europe’s second-largest stock exchange, lists nearly 800 companies valued over $4.5 trillion and operates the CAC 40 index. The CAC 40 closed near 8,045 on October 8, 2025, up about 10% year-to-date but below its March peak. Euronext N.V. joined the CAC 40 in September amid strong IPO activity and political turmoil following the French Prime Minister’s resignation. Average daily turnover is €4.1 billion.
Euronext Amsterdam Soars to New Heights: Europe’s Oldest Exchange Making History

Euronext Amsterdam Soars to New Heights: Europe’s Oldest Exchange Making History

Euronext Amsterdam, founded as the Amsterdam Stock Exchange in 1602, is the world’s oldest modern securities market. Now part of the Euronext group spanning seven countries, it lists over 140 companies including ASML, Shell, and ING. The exchange operates fully electronically from 9:00 a.m. to 5:30 p.m. CET, with oversight by Dutch regulators. Its AEX index had a free-float market cap of about €850 billion in early 2021.
London Stock Exchange at Record Highs – Inside the Historic Market’s Brexit Battle and 2025 Revival

London Stock Exchange at Record Highs – Inside the Historic Market’s Brexit Battle and 2025 Revival

The FTSE 100 closed at a record 9,548.87 on October 8, 2025, lifted by bank and gold miner stocks. London saw only 18 IPOs in 2024 and just three in the first nine months of 2025, the slowest pace since 2010. Over 150 companies have delisted or moved abroad since early 2024. The LSE lists firms from over 60 countries and runs one of the world’s longest trading days.
9 October 2025
Meme Coin Frenzy & Mega-Raises: Inside October 2025’s ICO and Token Sale Boom

Meme Coin Frenzy & Mega-Raises: Inside October 2025’s ICO and Token Sale Boom

Limitless (LMTS) drew $200 million in bids for a $1 million token sale, while Trump-backed World Liberty Financial (WLFI) closed pre-sales at $590 million in October 2025. Meme coins like Pepeto and “Pepe” spinoffs raised over $17 million combined. Bitcoin hit a record $125,000 and Ethereum neared $4,500. U.S. regulators dropped the Binance lawsuit and clarified Dogecoin’s status, boosting market sentiment.
9 October 2025
FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next

FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next

The FTSE 100 closed at a record high near 9,548 in early October, up 15–17% year-to-date, led by surges in banks, miners, and healthcare stocks. Gains followed strong earnings, regulatory relief, and gold topping $4,000/oz. A weak pound boosted international firms’ profits. Political shifts and a new UK-India trade deal also moved markets, while Middle East tensions kept oil and gold prices elevated.
1 245 246 247 248 249 358
Go toTop